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Planar cell polarity (PCP) refers to the collectiveorien-
tationof cellswithin theepithelial plane.Weshow that
progenitor cells forming the ducts of the embryonic
pancreas express PCP proteins and exhibit an active
PCPpathway. Planarpolarity proteins are acquired at
embryonic day 11.5 synchronously to apicobasal
polarizationof pancreasprogenitors. Lossof function
of the two PCP core components Celsr2 and Celsr3
shows that they control the differentiation of endo-
crine cells from polarized progenitors, with a preva-
lent effect on insulin-producing beta cells. This
results in a decreased glucose clearance. Loss of
Celsr2 and 3 leads to a reduction of Jun phosphoryla-
tion in progenitors, which, in turn, reduces beta cell
differentiation from endocrine progenitors. These
results highlight the importance of the PCP pathway
in cell differentiation in vertebrates. In addition, they
reveal that tridimensional organization and collective
communication of cells are needed in the pancreatic
epithelium in order to generate appropriate numbers
of endocrine cells.
INTRODUCTION
Polarization of cells in the plane of the epithelium, and perpen-
dicular to the apicobasal axis, is referred to as planar cell polarity
(PCP) (Seifert and Mlodzik, 2007) or tissue polarity. PCP medi-
ates cell communication and is important for organized cell
movements and morphogenesis of coherently repeated polar-
ized structures such as cilia, hair, or ommatidia. PCP has been
well characterized in Drosophila, where it was shown that core
components display polarized distribution (Bastock et al.,
2003; Chen et al., 2008; Gubb and Garcı´a-Bellido, 1982;
Shimada et al., 2001; Strutt and Strutt, 2008, 2009). In many
tissues, the Frizzled (FZD), Disheveled (DSH, or DVL in verte-
brates) complex is localized at one lateral side of cells, and the
strabismus/Van Gogh (STRBM, or VANGL), Prickle (PRK, orCell RePK) complex at the opposite side, whereas Flamingo (FMI, or
CELSR 1–3) is symmetrically localized and stabilizes the PCP
complexes (Strutt and Strutt, 2008). FMI encodes a protein larger
than 3,000 amino acids with N-terminal cadherin repeats,
a G-protein-coupled receptor proteolysis site (GPS), seven
transmembrane domains, and an intracellular C terminus.
CELSR1-3 are mammalian homologs of Drosophila Flamingo
(Usui et al., 1999) and are more than 50% identical in extracel-
lular and transmembrane regions but their cytoplasmic tails differ
(Tissir et al., 2005). In Drosophila, Fmi-null mutations are embry-
onically lethal as a result of defective longitudinal tracts in the
central nervous system (Usui et al., 1999). FMI is implicated,
with other PCP pathway components, in the organization of
ommatidia, cuticular hairs, wing cells, and sensory bristles in
Drosophila (Seifert and Mlodzik, 2007). This pathway is highly
conserved in vertebrates where it controls neural tube closure
(Wang et al., 2006c), convergent extension during gastrulation
(Wang et al., 2006a), and hair orientation or sensory cilia orienta-
tion in the inner ear (Curtin et al., 2003; Wang et al., 2006b). The
conservation of core PCP components and inactivation of PCP
genes in different organs shows that the PCP pathway regulates
morphogenesis in mammals. For example, in mice, inactivation
of Celsr1 perturbs neural tube closure, but also inner ear cell
and skin hair patterning due to a defect of PCP signaling (Curtin
et al., 2003; Devenport and Fuchs, 2008; Ravni et al., 2009).
Celsr3 mutation leads to axon tract development defects in the
central nervous system and to perturbed facial branchiomotor
neuron migration (Qu et al., 2010; Tissir et al., 2005). The
Drosophila ommatidia are a unique example showing that the
PCP can control the specification of cells, namely, photore-
ceptor R4 (Das et al., 2002).
In this article, we investigated the role of the PCP pathway in
pancreas development. The pancreas initially buds from the
posterior foregut. From embryonic day 8.5 (E8.5) to E10.5, this
bud expands to 500–1,000 multipotent progenitor cells that
express PDX1 and SOX9 (Ahlgren et al., 1996; Gu et al., 2002;
Lioubinski et al., 2003). At these stages, a few progenitors start
to express NEUROG3 and differentiate into endocrine cells,
mostly a cells expressing Glucagon (Johansson et al., 2007).
Between E11.5 and E14.5, the pancreas progenitors undergo
marked remodeling: they become apicobasally polarized andports 2, 1593–1606, December 27, 2012 ª2012 The Authors 1593
Figure 1. Celsr1, Celsr2, and Celsr3 Are Expressed in the Epithelium of the Pancreas
(A–H) In situ hybridization detecting Celsr1–3 mRNA expression was performed on 8 mm sections at E11.5 (A–C) and E14.5 (E–G). Celsr1 (A) and Celsr3 (C) are
detected at E11.5, but not Celsr2 (B). Celsr1 (E), Celsr2 (F), and Celsr3 (G) are expressed in the pancreatic epithelium at E14.5. Sense probes for Celsr1–3
exhibited no staining as shown for Celsr3 (D and H). (A–D) Dotted lines show the pancreatic bud. Scale bars, 25 mm (A–D) and 100 mm (E–H), n = 4.
See also Figure S1.align their apical sides to form ducts (Pan and Wright, 2011). By
E14.5, progenitors also become segregated into ductal/
endocrine bipotent progenitors in the center of the organ, lining
the ducts and exocrine progenitors at terminal end buds (Zhou
et al., 2007). At the same time, the progenitors continue to differ-
entiate into endocrine progenitors expressing NEUROG3 and
endocrine cells expressing Insulin (b), Somatostatin (d), Ghrelin
(ε), and Pancreatic Polypeptide (PP) and less Glucagon (a)
(Johansson et al., 2007). Many transcription factors have been
identified that play a role in endocrine cell differentiation (Pan
and Wright, 2011). In this study, we investigated the role of
cell-cell interactions and how they are constrained by the global
architecture of the organ. Recent evidence shows that interfering
with the apicobasal polarity of cells has impacts not only on the
morphogenesis of the entire organ but also on endocrine
differentiation (Kesavan et al., 2009; Villasenor et al., 2010). We
therefore investigated whether planar polarity, a pathway that
polarizes groups of cells perpendicular to the apicobasal axis,
also controls morphogenesis and differentiation.
We show that the core PCP components are expressed during
pancreas embryogenesis and are restricted to the epithelium,
precisely in pancreas progenitor cells. By deleting Celsr2 and
Celsr3, we establish that CELSRs maintain PCP pathway
signaling. The disruption of this pathway has little effect on gross
acinoductal structure but leads to a severe endocrine cell differ-
entiation defect. Finally, we show that this is caused bymodifica-
tion of JNK signaling in the ducts lined by progenitors.1594 Cell Reports 2, 1593–1606, December 27, 2012 ª2012 The AutRESULTS
Planar Polarity Proteins Are Expressed in Pancreas
Progenitors Lining Ducts
We initially identified Celsr3 as a gene that was 8.5-fold upregu-
lated 24 hr after inducing a NEUROG3 gain of function in the
pancreatic epithelium at E10.5. In the context of this profiling
experiment using Pdx1-Ngn3ER-IRES-GFP mice bred into
a Neurog3-null background (Gradwohl et al., 2000; Johansson
et al., 2007) (data available at http://www.betacell.org), two other
Wnt/PCP-related RNAs, glypican4, a positive modulator of non-
canonical Wnt signaling, andDvl1, were also upregulated (3- and
1.9-fold, respectively). Regulation of Celsr3 by NEUROG3 was
confirmed by quantitative RT-PCR (qRT-PCR) that showed
a 50% reduction of Celsr3 expression in Neurog3 knockout
(KO) at E11.5 (Figure S1A). At E14.5, Celsr3 expression was no
longer modified by Neurog3 gain or loss of function (data not
shown).
To investigate the role of CELSR3 during pancreas develop-
ment, we analyzed the spatial and temporal expression patterns
of Celsr1–3 transcripts by in situ hybridization (Figures 1A–1H).
Celsr1 andCelsr3 but notCelsr2were detected in the pancreatic
bud at E11.5 (Figures 1A–1C). Transcripts for Celsr1–3 were ex-
pressed broadly in the pancreatic epithelium at E14.5 (Figures
1E–1G), including in progenitors, exocrine cells, and endocrine
cells (Figures S1F–S1I). Expression was confirmed by qRT-
PCR on E14.5 wild-type (WT) pancreas (Figure 4A). To makehors
a more global assessment of the PCP pathway during pancreas
development, we first investigated the expression of other core
components of the PCP, by RT-PCR, and found that Prickle1
and 2, Vangl1 and 2, Dvl1, 2, and 3, and Fzd3 and 6 are tran-
scribed in the E14.5 pancreas (data not shown).
To gain further insight into the expression and cellular locali-
zation of core PCP proteins, we selected VANGL1, which is
localized asymmetrically on lateral sides of cells (Wang et al.,
2006b). VANGL1 protein becomes consistently detected by
E11.5, a stage when apicobasal polarity is first established
(Kesavan et al., 2009; Villasenor et al., 2010; Figure 2A). At
E11.5 small foci of VANGL1 expression appeared close to the
Mucin1 foci marking apical membranes (Figure 2B). At E12.5,
the central progenitors expressed membranous VANGL1 but
not the tips containing multipotent progenitors (Figures S1B
and S1C). After the secondary transition (at E13.5), VANGL1
was detected along the lateral membranes of ductal cells and
was apically enriched (Figures 2C, 2D, 2I, and 2J), as reported
in other epithelia (Montcouquiol et al., 2006; Shimada et al.,
2001; Strutt and Strutt, 2008; Strutt et al., 2011). To determine
whether VANGL1 was ubiquitously expressed or restricted to
specific cell types, immunostainings against VANGL1 and spe-
cific pancreatic markers were performed. We observed that
VANGL1 is restricted to PDX1+ and (Figures 2E and 2E0) SOX9+
pancreatic progenitor cells (data not shown), and to NEUROG3+
endocrine progenitors cells (Figures 2F and 2F0). However, no
membranous VANGL1 was detected in Insulin+ or Glucagon+
cells (Figures 2G–2H0) or in the acinar compartment at the tip of
ducts (Figures 2C, 2E, and 2E0, dotted line). VANGL1 is detected
in the duct of adult mice (Figures S1D and S1E) even when they
have lost progenitor properties (Kopp et al., 2011; Solar et al.,
2009).
The Planar Polarity Protein Celsr3 Enables Beta Cell
Differentiation
To investigate whether PCP is required for proper pancreas
organogenesis, we deleted the PCP core component Celsr3 in
mice. Quantification of immunostained sections of Celsr3 KO
mice (Tissir et al., 2005) at E14.5 revealed an increase of the
PDX1+ (Figures S2A and S2B) and SOX9+ (data not shown)
progenitor cells as well as of the pancreas size. However, this
expansion was transient as the size of the pancreas was unaf-
fected at E11.5 and E18.5 (Figures S2C and S2D). Starting
from E14.5, we observed a decrease of Insulin+ cells in the KO
(Figures 3A–3C), whereas Glucagon+, Somatostatin+, Ghrelin+,
and Pancreatic Polypeptide+ cells were unaffected (Figures
S2E–S2H). To ascertain that the phenotype observed was due
to the function of Celsr3 in the pancreas epithelium, we specifi-
cally inactivated Celsr3 in epithelial pancreas progenitors. We
bred Celsr3 flox/flox mice (Zhou et al., 2008) with mice express-
ing a Cre recombinase under the control of the Pdx1 promoter
(Pdx1-Cre) (Hingorani et al., 2003). In contrast to Celsr3 KO,
Celsr3 flox/flox; Pdx1-cre (abbreviated Celsr3 f/f; Cre) did not
exhibit the transient increase of pancreatic progenitor cells
(SOX9+ cells) (Figure S2I) or of the pancreas size (Dapi+ cells)
(Figure S2J), possibly because the Pdx1-cre driver leads to
delayed or partial recombination. The efficiency of deletion
was tested by qRT-PCR at E14.5 and showed a recombinationCell Rerate of 70% in Celsr3 f/f; Cre (Figure S2L). This efficiency is
underestimated since an E14.5 pancreas contains about 10%
of mesenchyme, which is not targeted by Pdx1-Cre (Landsman
et al., 2011). As in the KO at E14.5, we observed a reduction of
Insulin+ cells (Figure 3D), whereas Glucagon+ cells were
unchanged (Figure S2K). Embryos die at P0 after deletion of
Celsr3 most likely due to axonal tract development defects
that impair breathing (Tissir et al., 2005), whereas the pancreas
specific deletion circumvents the postnatal death. Intraperito-
neal glucose tolerance tests on 4-month-old Celsr3 f/f; Cre
mice revealed a diminished glucose clearance capacity (Fig-
ure 3E). Glucose-stimulated insulin secretion (GSIS) in isolated
sizematchedpancreatic islets from4-month-oldmice (Figure 3F)
showed that islets fromCelsr3 f/f and Celsr3 f/f; Cremice did not
display any difference in GSIS, indicating that the defect of
glucose clearance is not caused by an insulin secretion defect.
Thus, we quantified the beta cell population in 4-month-old
Celsr3 f/f and Celsr3 f/f; Cremice and found that this population
was decreased (Figure 3G). Altogether, our findings show that
Celsr3 is needed to generate enough beta cells for appropriate
glycemic control.
Celsr2 and Celsr3 Have Redundant Functions in
Pancreas Development and Promote Endocrine Cell
Differentiation
It was previously shown that Celsr2 and Celsr3 have redundant
functions in ependymal cilia development (Tissir et al., 2010)
andCelsr1 andCelsr2 are also detected in the pancreatic epithe-
lium during development (Figures 1E and 1F). We quantified
Celsr1 and 2mRNA in Celsr3 KOmice. Celsr2mRNA was signif-
icantly increased in Celsr3 KO pancreatic buds at E14.5 (Fig-
ure 4A). Thus, we studied the effect of combined deletion of
Celsr2 and Celsr3 (DKO) during pancreas development.
Celsr2+3 DKO embryos showed a normal pancreatic progenitor
cell population at E14.5 (SOX9+ cells) (Figure S3A) and a normal
pancreas size (Dapi+ cells) (Figure S3B). Starting from E14.5, we
observed a drastic decrease in Insulin+ cells (Figures 4B–4D) as
well as a reduction in all the other endocrine cell populations
(Figures 4E-4H). Quantification of the SOX9+, NEUROG3+,
Insulin+, Glucagon+ cells, at E14.5 and E18.5 in Celsr2 mutant
mice (Tissir et al., 2010) did not reveal any deviation from WT
(Figures S3D–S3F). Thus, Celsr3 is essential for the specification
ofmultipotent progenitors into endocrine cells andCelsr2 substi-
tutes for Celsr3 when the latter is deleted. Beta cells are themost
sensitive to the reduction of combined Celsr alleles.
Celsr2 and Celsr3 Maintain the PCP in the Pancreas
It was previously shown that disruption of the PCP signaling
leads to a positioning defect of PCP proteins to the membrane
(Shimada et al., 2001; Tissir et al., 2010). Therefore, to investigate
the mechanism of action of Celsr2+3, and to assess whether
PCP mediates their function, we studied the localization of
Vangl1 in Celsr2+3 DKO pancreas. We observed that VANGL1
was decreased at the membrane of Celsr3 KO and almost
absent in Celsr2+3 DKO (Figures 5A–5C). We could observe
the same reduction of FZD3, another PCP core protein, at the
membrane of Celsr2+3 DKO (Figures S4A and S4B). Further-
more, C-JUN N-terminal kinase (JNK) is activated by PCPports 2, 1593–1606, December 27, 2012 ª2012 The Authors 1595
Figure 2. The Planar Cell Polarity Protein VANGL1 Is Restricted to Progenitor Cells
Representative sections of E10.5–E18.5 WT pancreata immunostained against the indicated antigens (A–H).
(A) E10.5 pancreas section immunostained with antibodies against PDX1 (white), pancreatic progenitor marker, and VANGL1 (red). No reproducible VANGL1
signal is detected, only random background.
(B) E11.5 pancreas section immunostained with antibodies against PDX1, Mucin1 (white), apical marker, and VANGL1 (red). VANGL1 is enriched close to the
apical surface of cells.
(C and D) E14.5–E18.5 pancreas sections stained with Dapi (blue) and antibodies against ECAD (red), epithelial marker, Mucin1 (green), and VANGL1 (white).
VANGL1 is expressed in the ductal compartment but not in the exocrine compartment delimited by the dotted line, preferentially at the apicolateral surface of cells
(arrowhead).
(E–H) E14.5 pancreas sections immunostained with antibodies against PDX1, NEUROG3, endocrine progenitor marker, Insulin (INS) or Glucagon (GCG) (green),
and VANGL1 (white). PDX1+ and NEUROG3+ cells are VANGL1+, whereas INS+, GCG+ cells and the acinar compartment (dotted line) are VANGL1. (E0–H0) Only
VANGL1 (white) is shown. Scale bars, 10 mm.
(legend continued on next page)
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signaling in multiple organs (Boutros et al., 1998; Weber et al.,
2000; Yamanaka et al., 2002). Therefore, we tested whether
JNK activity was altered inCelsr3KO andCelsr2+3DKOpancre-
atic buds by measuring the level of its target phospho-JUN.
Consistently, phospho-JUN was downregulated in the mutants
as compared with the WT by western blot (Figures 5D–5F).
Together, these experiments show that PCP signaling is greatly
reduced in Celsr 2+3 DKO. Although Flamingo, the Drosophila
Celsr2/3 homolog, is an atypical cadherin that can play a role in
adhesion (Usui et al., 1999), E-cadherin (Figures S4E and S4F),
ZO-1 immunostainings (data not shown), and electron micros-
copy (Figures S4C and S4D) failed to reveal disrupted adherens
junctions in Celsr 2+3 DKO.
Celsr2 andCelsr3Control EndocrineCell Differentiation
Downstream of Neurog3
To elucidate the mechanism leading to endocrine cell reduction,
we first assayed proliferation of beta cells by injecting EdU 1 hr
before collecting embryonic pancreata. Quantification of EdU/
insulin double-positive cells at the stage of maximal proliferation,
in E18.5 embryos, did not reveal differences betweenCelsr3 KO,
Celsr2+3DKO, andWTmice (Figures 5G–5I). Although the prolif-
eration defect may have been earlier, Ki67 immunohistochem-
istry in WT pancreas at E14.5 revealed a very low proliferation
rate of beta cells (2%) and no NEUROG3+ cells were found to
be Ki67 positive (data not shown). With this low basal prolifera-
tion rate, detecting a decrease of proliferation is rather unlikely.
We also quantified the proliferation at E11.5 in WT and Celsr3
KO and did not detect any difference (data not shown).
Apoptosis, monitored by cleaved caspase-3, was minimal at
E14.5 and similar between WT and the different Celsr mutant
mice (data not shown). Thus, these results show that proliferation
and apoptosis are unlikely to account for the reduction in
endocrine cells. PDX1+ and SOX9+ progenitors give rise to
NEUROG3+ cells, which will then differentiate into endocrine
cells. Quantification of NEUROG3+ cells did not reveal any differ-
ence at E14.5 inWT versusCelsr3KO,Celsr3 f/f;Cre orCelsr2+3
DKO embryos (Figures 5J–5L). However, the number of cells ex-
pressing INSM1 and NKX2-2, two transcription factors required
for endocrine cell differentiation that are directly induced by
NEUROG3 (Gierl et al., 2006; Mellitzer et al., 2006; Smith et al.,
2004), was decreased at E14.5 in Celsr3 f/f; Cre and Celsr2+3
DKO mice (Figures 5M–5O and S3C). These data show that
the deletion of Celsr3 results in a differentiation defect occurring
downstream of the NEUROG3+ stage rather than changes in
proliferation or apoptosis. The reduction in INSM1-positive cells
suggests that NEUROG3+ cells may have a slower differentiation
rate or revert to bipotent progenitors. Such reversions have been
observed upon reduction of NEUROG3 activity (Magenheim
et al., 2011; Wang et al., 2009). Short-term lineage tracing in
Celsr3/;Neurog3EYFP/+ embryos (Mellitzer et al., 2004), based
on the perdurance of YFP signals after NEUROG3 expression(I) Localization of VANGL1 along the lateral membrane of cells. Measurement of
shows a predominant expression at the apicolateral side of the cell (n = 31). The lim
the absolute length of the membrane. The distance from the apical (Mucin1) to t
(J) Area under the curve of apical VANGL1 versus basal VANGL1 intensity (n = 3
***p < 0.0001. Bars show SDs and p values are calculated according to Mann-W
Cell Redid not reveal an increased contribution to the ductal (HNF1B+
and NEUROG3) or acinar fate (carboxypeptidase A) at E14.5
and E18.5 (data not shown). However, longer-term lineage
tracing cumulating the fate of NEUROG3+ cells over time in
Celsr3/; Neurog3-cre; Rosa26-YFP mice (Schonhoff et al.,
2004; Srinivas et al., 2001) revealed a great increase in the contri-
bution to ductal but not to acinar compartment (Figures 6A–6J).
The total number of YFP+ cells was similar in both backgrounds,
confirming that over time NEUROG3+ cells are generated in
normal numbers but are in part rerouted to a ductal fate.
Celsrs Control Beta Cell Differentiation via the Jnk
Pathway
JNK mediates some PCP activities in the Drosophila eye (Weber
et al., 2000) and during convergent extension in Xenopus (Yama-
naka et al., 2002). Since we observed reduced phospho-JUN
upon Celsrs inactivation, the control exerted by Celsrs over
endocrine differentiation may be due to impaired JNK activity.
JUN is detected by immunohistochemistry in PDX1+ progenitors
(Figures 7A and 7A0), in the mesenchyme and is also expressed
at lower level in some NEUROG3+ endocrine progenitors cells
(Figures 7B and 7B0). However, no JUN is detected in Insulin+
and Glucagon+ cells (Figures 7C and 7C0) or in the acinar
compartment (Figures 7D and 7D0). The localization of JUN in
the epithelium is thus in the same cell population as the PCP
protein VANGL1 (Figures 2E–2H). This global distribution pattern
was unaltered in the DKOs although global phospho-JUN levels
were decreased. To test whether blocking JNK affects endocrine
cell generation, we treated WT pancreatic explants with
a specific JNK inhibitor, SP600125 (Bennett et al., 2001), at
a time when progenitors start to differentiate into endocrine
beta cells (E12.5). We analyzed the explants treated with
SP600125 after culturing for 48 hr (E14.5). We found that inhibit-
ing JNK activity leads to a decrease of the Insulin+ cell number,
whereas the PDX1+ cells were unchanged as compared with WT
explants treated with the carrier (Figures 7E–7G). The number of
Glucagon+ cells was unchanged but a large proportion of these
cells were already differentiated at the time of treatment (Johans-
son et al., 2007). Furthermore, we did not detect any decrease of
the NEUROG3+ cells or of the proliferation rate of the total pop-
ulation (Figures S5A and S5B). No Insulin+ cells were found
proliferating in explants. Since blocking JUN activity mimics
Celsr3mutants, we attempted to rescue JNK signaling in Celsr3
KO, we treated E12.5 Celsr3 KO pancreatic explants with a JNK
agonist, anisomycin (Cano et al., 1994). We analyzed the ex-
plants treated with anisomycin after culturing for 48 hr (E14.5).
A general hypoplasia was measured by a decrease of PDX1+
cells (Figure 7I). We therefore measured the endocrine differen-
tiation flux by normalizing to the PDX1+ cells and observed
a reduction of Insulin+ cells in absolute and relative numbers (Fig-
ure 7H). This argues that hyperactive JNK pathway activity limits
progenitor expansion and promotes beta cell differentiation.VANGL1 intensity signal at E18.5 along the apicobasal axis of the membrane
it between apical and basal side of themembrane is positioned at themiddle of
he basal (mesenchyme) is set to normalize between the different cells.
1).
hitney U test.
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Figure 3. Celsr3 Deletion Results in Decreased b Cell Population and Glucose Intolerance
(A and B) E14.5 WT and Celsr3 KO serial pancreas sections were stained with Dapi (blue), and antibodies against Insulin (INS; red) and Glucagon (GCG; green).
Scale bar, 50 mm.
(C and D) INS/Dapi area was quantified at E14.5 and E18.5. In Celsr3 KO embryos, INS area is significantly reduced compared to WT (n = 4), *p < 0.05. (D) E14.5
Celsr3 f/f and Celsr3 f/f; Cre were stained with Dapi (blue) and an antibody against Insulin. INS/Dapi area was quantified at E14.5. In Celsr3 f/f; Cre embryos, INS
area is significantly decreased compared to WT (n = 4), *p < 0.05.
(E) Intraperitoneal glucose tolerance tests were performed on 4-month-old Celsr3 f/f and Celsr3 f/f; Cre mice, fasted for 16 hr. Glucose (2 g/kg) was administered
at time 0. Each point represents the mean of nine mice. Basal fasting blood glucose levels are similar between the two groups of mice. The Celsr3 f/f; Cre mice
exhibit significantly higher blood glucose levels. (n = 9), **p < 0.001, ***p < 0.0001.
(F) Insulin secretion normalized to total Insulin content inCelsr3 f/f andCelsr3 f/f; Cre islets at the indicated glucose concentrations (n = 4mice for each genotype).
No differences are observed.
(G) INS/Dapi area was quantified at 4 months. In Celsr3 f/f; Cre adults, INS area is significantly decreased compared to WT (n = 4), *p < 0.05. Bars show SDs and
p values are calculated according to Mann-Whitney U test.
See also Figure S2.DISCUSSION
In this study, we have investigated whether the tissue polarity
pathway that coordinates individual cell characters in communi-
ties of cells impacts the development of the pancreas. Although
the role of the PCP in orienting cells has been demonstrated in
multiple contexts in vertebrates our experiments reveal that the
PCP also controls cell type specification in vertebrates, namely,1598 Cell Reports 2, 1593–1606, December 27, 2012 ª2012 The Autendocrine cell specification in the pancreas. The only other
evidence to our knowledge is the specification of photoreceptors
in the Drosophila ommatidia (Das et al., 2002).
The PCP Promotes Endocrine Cell Differentiation
We found that constitutive or pancreas-specific deletion of
Celsr3 results in a reduction in Insulin+ cell differentiation and
further elimination of Celsr2 alleles potentiates this effect andhors
Figure 4. Celsr3 and Celsr2 Promote Endocrine Cell Differentiation
(A) qRT-PCR analysis on E14.5 WT and Celsr3 KO embryos shows an increase in the relative expression of Celsr2 (n = 4), *p < 0.05.
(B and C) Serial pancreas sections from E18.5 WT and Celsr2+3 DKO embryos (DKO) were stained with Dapi (blue) and antibodies against INS (red) and GCG
(green). Scale bar, 100 mm.
(D) At E14.5 and E18.5, INS/Dapi area was quantified. In DKO embryos, INS area is decreased compared to WT (n = 4), *p < 0.05.
(E) At E14.5 and E18.5, GCG/Dapi area was quantified. In DKO embryos, GCG area is decreased compared to WT (n = 4), *p < 0.05.
(F–H) The Ghrelin+, Pancreatic Polypeptide+, and Somatostatin+ cells were quantified at E18.5. In DKO embryos, Ghrelin+, Pancreatic Polypeptide+, and
Somatostatin+ cells are decreased compared to WT (n = 4), *p < 0.05.
Bars show SDs and p values are calculated according to Mann-Whitney U test. See also Figure S3.reduces all other endocrine cell types. Adult mice with a specific
deletion of Celsr3 in PDX1+ pancreatic progenitor cells display
glucose intolerance but no functional Insulin secretion defect
indicating that CELSRs alter the embryonic endocrine differenti-
ation program and ultimately the number of beta cells in adults.
We demonstrate that Celsrs are expressed in the pancreas
epithelium and control endocrine cell differentiation in this
compartment. Moreover, we observe a restriction of VANGL1
and the PCP downstream component cJun to PDX1+/SOX9+Cell Reprogenitors and NEUROG3+ endocrine progenitors and their
decrease upon Celsr2+3 inactivation. These results suggest
that the activity of CELSRs via the PCP in one or both of these
progenitor populations leads to reduced endocrine cells.
Although the numbers of NEUROG3+ cells was normal in allCelsr
KOs the reduction of the cells expressing its targets INSM1 and
NKX2-2 suggests that their differentiation is arrested after
NEUROG3 expression. Lineage tracing shows that a subset of
NEUROG3+ cells are rerouted to the ductal compartment,ports 2, 1593–1606, December 27, 2012 ª2012 The Authors 1599
(legend continued on next page)
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most likely through a bipotent progenitor state. Our interpreta-
tion is that the PCP controls either NEUROG3 activity or
a NEUROG3 cofactor and that less cells would reach the
NEUROG3 threshold to turn on NEUROG3 target genes and
further differentiate in the Celsr KOs. The induction of this
cofactor may occur either in PDX1+/SOX9+ progenitors or in
NEUROG3+ progenitors. This is consistent with the observation
that similar reversions have been observed with increased
frequency upon reduction of NEUROG3 activity (Magenheim
et al., 2011; Wang et al., 2009). The reduction of INSM1 and
NKX2-2 are consistent with the reduction in endocrine cells
but cannot cause the reduced endocrine cell numbers. Indeed,
Insm1 inactivation results in reduced endocrine cell numbers
but a large proportion of the cells accumulate in an undif-
ferentiated state (Mellitzer et al., 2006) and Nkx2-2 deletion
results in their conversion to Ghrelin-expressing cells (Prado
et al., 2004), two outcomes that we have not observed in Celsr
mutants. The minimal proliferation of NEUROG3+ and absence
of proliferation of INSM1+ cells we measured in WT makes it
unlikely that reduced proliferation at this stage leads to reduced
beta cell numbers. Although we did not detect apoptosis, cell
death is a fast process and an effect on apoptosis remains
possible. Although in the Drosophila ommatidia defects in
Notch signaling caused by PCP pathway impairments medi-
ated the specification of R3 versus R4 photoreceptors (del
Alamo and Mlodzik, 2006; Fanto and Mlodzik, 1999), no
changes in the Notch pathway targets Dll1 or Hes1 were ob-
served in the pancreas of Celsr3 and Celsr2+3 DKO by quanti-
tative RT-PCR.
UponCelsr3 inactivation, we did not observe a decrease of the
Glucagon+ cells. Our interpretation is that since the PCP is
established from E11.5 to E12.5, deletion of Celsrs may only
affect late differentiation of endocrine cells. Hence, as a large
proportion of Glucagon+ cells are specified between E9.5 and
E12.5, unlike other endocrine cell types, they would be less
affected. Their decrease may be detected only when the PCP
pathway is strongly inactivated as in Celsr2+3 DKO, thereby
making detectable the reduced production of Glucagon cells
differentiating after E12.5. This is consistent with the fact that
the lineage tracing does not reveal rerouting to the acinar
compartment, which we would expect to see if NEUROG3+ cells
were converted to the multipotent progenitors residing in the
pancreas before E11.5.Figure 5. CELSR2+3 Function via PCP Signaling and Control Endocrin
(A–C) E14.5 WT, Celsr3 KO, and Celsr2+3 DKO serial pancreas sections were s
Mucin1 (green), and VANGL1 (white). Scale bar, 50 mm. VANGL1 is reduced at th
(D) Western blot against phospho-JUN. Celsr3 and Celsr2+3 deletion resulted in lo
E14.5 pancreas per lane).
(E and F) Mean of the quantification of the band intensity forCelsr3 KO andCelsr2+
to t test, hypothesizing a standard normal distribution.
(G and H) Serial pancreas sections of E14.5 WT and Celsr3 KO were stained with
(I) The percentage of Insulin+ cells that costained with EdU is not different betwe
(J and K) Serial pancreas sections of E14.5 WT and Celsr3 KO were stained
Scale bar, 50 mm.
(L) Quantification of the number of NEUROG3+ cells in WT, Celsr3 KO, Celsr3 f/f
(M and N) Serial pancreas sections of E14.5 WT and Celsr3 KO embryos were sta
(O) Quantification of INSM1+ cells shows a significant decrease in Celsr3 f/f; Cre
Bars show SDs and p values are calculated according to the Mann-Whitney U te
Cell ReEven though endocrine cells are strongly decreased in
Celsr2+3 DKO, their differentiation is not completely impaired.
This could be due to a role of the third homolog of Fmi, Celsr1,
which may substitute for Celsr2 and Celsr3 when both are
deleted. However no compensatory Celsr1 upregulation was
observed in theCelsr2+3 KO, and to the contrary, it was reduced
by 50% (data not shown). Nevertheless, the persistence of low
levels of VANGL1 and FZD3 at the membrane in the Celsr2+3
DKO suggests that the PCP pathway retains some activity.
The JNK Pathway Regulates Beta Cell Induction
Downstream of the PCP
We found that JUN has the same expression pattern as the PCP
proteins VANGL1 in progenitor cells but not in endocrine or
acinar cells. In agreement with this, we found that deletion of
Celsrs leads to a decrease of phospho-JUN, suggesting that,
as in other systems (Boutros et al., 1998; Weber et al., 2000;
Yamanaka et al., 2002), the JNK pathway may mediate at least
part of the function of Celsr/PCP complexes in the pancreas
(Lapebie et al., 2011). This is a global decrease in each progen-
itor rather than the disappearance of specific cell types as the
global JUN staining pattern remains the same in Celsrs KOs.
Moreover, JNK pathway inhibition ex vivo impairs Insulin+ cell
differentiation, as does the inactivation of Celsrs. In addition,
the JNK agonist anisomycin applied on pancreatic explants
ex vivo resulted in an increased beta cell differentiation flux
from progenitors in the Celsr3 KO, indicating that the JNK
pathway promotes beta cell differentiation, and possibly more
generally endocrine development. The reduction of phospho-
JUN in Celsr mutants shows that JUN acts at least in part
downstream of Celsrs. Hypoplasia was also observed upon
JUN overactivation, which could be explained by the fact that
overactive JNK triggers endocrine differentiation depleting the
pool of progenitors. No defect in adherens junction was de-
tected, thus suggesting that the endocrine cell reduction is not
due to adhesion defects either.
Absence of Cysts in PCP-Deficient Mice
In the kidney, strong interferences with the Fat/Dachsous PCP
pathway synergizing with Vangl2, leads to the formation of ductal
enlargements named cysts (Bacallao and McNeill, 2009; Saburi
et al., 2008). Impairment of the function of Inversin, a gene that
controls canonical Wnt pathway and planar polarity (Simonse Differentiation Downstream of NEUROG3
tained with Dapi (blue), and antibodies against ECAD (red), epithelial marker,
e plasma membrane of Celsr3 KO and almost absent in Celsr2+3 DKO (n = 4).
wer PCP signaling level (n = 3 independent experiments, each on three pooled
3DKO (n = 3). *p < 0.05. Bars show SDs and p values are calculated according
Dapi (blue) EdU (red), proliferation marker, and INS (green). Scale bar, 50 mm.
en WT, Celsr3 KO, and Celsr 2+3 DKO embryos (n = 4).
with Dapi (blue) and antibodies against SOX9 (red) and NEUROG3 (green).
; Cre, and Celsr 2+3 DKO embryos did not show any difference (n = 4).
ined with Dapi (blue) and antibodies against INSM1 (green). Scale bar, 50 mm.
and Celsr2+3 DKO compared to the WT. (n = 4), *p < 0.05.
st. See also Figures S4 and S6.
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Figure 6. Fate of Endocrine Progenitor Cells in Celsr3 KO Pancreas
(A–F) E18.5Neurog3-Cre; Rosa26-YFPmice harboringWT orCelsr3KO alleles
immunostained with antibodies against DBA-lectin, ductal marker (white), YFP
1602 Cell Reports 2, 1593–1606, December 27, 2012 ª2012 The Autet al., 2005) causes cyst formation in the pancreas in addition to
the kidney, suggesting a role of PCP in preventing cyst formation
in the pancreas. However, no cyst was detected in Celsr2+3
DKO or any single mutant in the kidney and pancreas. It is
possible that the remaining Celsr1 protein is sufficient to prevent
cyst formation or that Celsrs and possibly the PCP pathway do
not control ductal diameter in the pancreas. Also, motile cilia
formation is impaired in the ependyma of Celsr2+3 DKO (Tissir
et al., 2010). Since cilia defects can cause cysts in the pancreas,
we investigated cilia in Celsr2+3 DKO and found that their struc-
ture and occurrence were normal by serial electron microscopy
(Figure S6). CELSRs may thus control cilia formation only in
some organs or their role may be restricted to motile cilia
assembly.
Acquisition of Polarity
VANGL1 starts to be detected at E11.5 in the pancreatic epithe-
lium coinciding with the establishment of apicobasal polarity
(Kesavan et al., 2009). Since the PCP factors are apicolaterally
localized, the establishment of apicobasal polarity may be
a requirement for the establishment of planar polarity and apico-
basal determinants may cooperate with PCP factors (Courbard
et al., 2009).
Although the PCP proteins were detected at the membrane in
the progenitors aligned in the embryonic ducts, it is unclear
whether there are two protein complexes restricted to opposing
sides of cells as in Drosophila or in the mouse inner ear (Seifert
and Mlodzik, 2007) or skin (Devenport and Fuchs, 2008). The
membranes of two adjacent cells can indeed not be reliably
discriminatedwith conventional microscopy. How an asymmetry
in expression may control differentiation remains to be eluci-
dated even if asymmetric cell division or asymmetric repartition
of key receptors for privileged reception of a ligand may be
invoked.
In vitro differentiation of beta cells from ES cells, for the
purpose of cell therapy of diabetes, has greatly progressed in
the past years but the final step of production of endocrine cells
from pancreas progenitors is ineffective in 2D cultures, although
the progenitors reveal their potential to differentiate into beta
cells when transplanted in vivo (Kroon et al., 2008). Previous
work has shown that proper apicobasal polarity is required for
beta cell production in vivo and our experiments demonstrate
that PCP also promotes endocrine differentiation. The imple-
mentation of culture conditions with controlled polarization in
3Dmay thus help promote the differentiation of beta cells in vitro.(green), and Insulin/Glucagon, endocrinemarker (red). Arrowheads showYFP+
cells that are DBA+.
(G) Number of cells that are YFP+ and DBA+, normalized on the total DBA+ cells
in pancreas. In Celsr3 KO embryos we observed that 35% progeny of
NEUROG3-expressing cells remain confined within the DBA+ epithelium cells
compared to 15% in the WT (n = 3).
(H) Number of cells that are YFP+ and DBA+, normalized to the total YFP+ cells
in pancreas (n = 3).
(I) Number of cells that are YFP+ andCPA+, normalized to the total YFP+ cells in
pancreas (n = 3).
(J) Number of cells that are YFP+, normalized to the total Dapi+ cells in
pancreas (n = 3). No difference was observed. Scale bar, 10 mm.
Bars show SDs and p values are calculated according to the t test.
hors
Figure 7. Celsr2+3 Control Beta Cell Differentiation via the JNK Signaling Pathway
(A–D) E14.5 pancreas section immunostained with antibodies against PDX1, NEUROG3, INS and GCG, CPA, and Jun. (A and A0) PDX1+ progenitors located in
cords are JUN+. (B–D0) Most of the NEUROG3+ endocrine progenitors are JUN+, although at a lower level than neighboring PDX1+ cells, whereas INS+ and CGC+
cells (endocrine cells) and CPA+ cells (acinar cells) are JUN. (A0) PDX1 only (red). (B0–D0) Only JUN (green). Scale bar, 10 mm.
(E–G) E12.5WT pancreatic explants were treated with DMSO or with 5 mMSP600125, a JNK inhibitor, diluted in DMSO for 48 hr. Quantification of immunostained
explants for Insulin, Glucagon, and PDX1. The number of INS+/PDX1+ cells is significantly decreased (n = 4), *p < 0.05.
(H and I) Rescue experiment treating E12.5 Celsr3 KO pancreatic explants with water or with 50 ng/ml of anisomycin, a JNK agonist, diluted in water for 48 hr.
Quantification of immunostained explants for Insulin and PDX1. The number of PDX1+ cells is reduced by anisomycin. The number of INS+/PDX1+ cells is
significantly increased (n = 4), *p < 0.05. Quantifications of INS cells were normalized to PDX1 to measure a differentiation flux from progenitors in these
experiments where PDX1 cell numbers were affected by one of the compounds. Although some PDX1+ cells also express Insulin, their relative number is
negligible.
Bars show SDs and p values are calculated according to the Mann-Whitney U test. See also Figure S5.
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EXPERIMENTAL PROCEDURES
In Situ Hybridization
In situ hybridization was conducted as described previously (Gouzi et al.,
2011). Probes are specified in Supplemental Information.
Immunofluorescence
Mouse embryos were fixed in 4% paraformaldehyde for 30 min to 1 hr at room
temperature or overnight at 4C. After several washes in 1 3 PBS, embryos
were equilibrated in 15% sucrose (Applichem) in Phosphate Buffer 0.12 M
prior to embedding in 7.5% gelatin (Sigma), 15% sucrose in phosphate buffer
0.12 M. Gelatin blocks were subsequently frozen in 65C 2-methylbutane
(isopentane, Acros Organics) and kept at 80C until sectioning. Frozen
sections (8 mm) were then dried at room temperature and washed in 1 3
PBS, before 30 min blocking in 1% BSA. Primary antibodies were incubated
overnight at 4C. A primary antibody list is provided in Supplemental Informa-
tion. Secondary antibodies were incubated 1 hr at room temperature. Alexa
Fluor secondary antibodies (all from Molecular Probes-Invitrogen) were used
for multicolor detection. Nuclei were stained with DAPI (50 ng/ml; Sigma).
The sections were mounted in 50% PBS:50% glycerol with a coverslip
covering the entire surface of the slide. All fluorescence microscopy images
were taken with a Leica DM5500 or a Zeiss LSM700 confocal microscope.
Immunoblotting
Mice were killed and pancreatic buds were taken and frozen in liquid nitrogen.
Pancreas were disrupted mechanically and sonicated. Antibodies against
phospho-JUNSer73 (cell signaling) and gamma-tubulin (Sigma) were used.
Electron Microscopy
Pancreata were fixed by perfusion with 5% glutaraldehyde and 2% parafor-
maldehyde in 0.1 M PBS (pH 7.4) and were postfixed for 1 hr in 1% osmium
tetroxide and 1.5% potassium ferrocyanide in cacodylate buffer (0.1 M,
pH 7.4). Thin serial sections were stained with uranyl acetate and lead citrate,
and observed with a FEI Tecnai Spirit 120 kV transmission electron
microscope.
Mouse Strains
Mouse lines we used were previously described and are referenced in the
result section. The Swiss Veterinary Office approved all animal experiments.
Embryos were collected at indicated times; midday on the day of vaginal
plug appearance was considered E0.5. The Tg(Neurog3-cre)C1Able and
Gt(ROSA)26Sortm1(EYFP)Cos lines are respectively simplified as Neurog3-Cre
and Rosa26-YFP in the results.
Genotyping
For genotyping, biopsies or embryonic mouse tissue collected during dissec-
tion were digested in 100–200 ml of DirectPCR tail buffer (Viagen-Biotech) with
2.5 ml of Proteinase K recombinant PCR grade (Roche Applied Sciences) in
a heating block at 55C overnight. Proteinase K was inactivated at 85C during
45 min. PCR was run using 2 ml of lysate and the primers described in the
respective references.
Quantification and Statistical Analysis
For quantification, the entire pancreas was serially sectioned. The total number
of cells per pancreas was obtained by counting immunopositive cells on every
6th (E14.5), 8th (E18.5), or 20th section (4 months). For explants, sections were
collected in four consecutive series. For NEUROG3, INSM1, NKX2-2, Ghrelin,
Somatostatin, and Pancreatic Polypeptide positive cells (matching a Dapi+
nucleus) were counted manually. For Insulin, Glucagon, PDX1, SOX9, and
Dapi, the positive pixels (surface of section) were quantified. All values are
shown as mean ± SD with n numbers and internal replicates indicated in the
figure of the legend; p values were calculated using the nonparametric
unpaired Mann-Whitney test unless otherwise indicated; p < 0.05 was consid-
ered significant.
Quantitative Real-Time PCR
Methods and primers are provided in the Extended Experimental Procedures.1604 Cell Reports 2, 1593–1606, December 27, 2012 ª2012 The AutGlucose Tolerance Test
For glucose tolerance tests, blood samples were obtained from the tail vein of
overnight-fastedmice to measure glucose levels using a freestyle pen (Abbott,
USA). Samples were measured immediately before and 15, 30, 45, 60, and
90 min after intraperitoneal injection of 2 g/kg glucose.
Insulin Secretion
Pancreatic islets were isolated via bile duct collagenase digestion
(Collagenase P, Roche) left to recover overnight at 37C in RPMI 1640 with
10% FBS, 1% L-glutamine and 1% penicillin/streptomycin. For insulin release
assays, 15 islets of matched size were statically incubated in Krebs-Ringer
Buffer and stimulated for 30 min at 37C with various glucose concentrations,
2.8 or 15 mM. Supernatant was collected and assayed for insulin content by
ELISA. Islets were then sonicated in acid-ethanol solution and solubilized
overnight at 4C before assaying total insulin content by ELISA.
Culture of Pancreatic Explants
E12.5 dorsal pancreatic buds were dissected and cultured on Millipore filters
for 2 days in culture medium (BioWhittaker Medium 199, 10% fetal calf serum,
1%penicillin-streptomycin) in the presence or absence of 10 mMJNK inhibitor,
SP600125 (Calbiochem) or 50 ng/ml JNK agonist, anisomycin (Sigma). The
culture medium was changed every day and, by the end of the culture period,
explants were embedded in gelatin and processed as described above for
immunostaining analysis.
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